Panic disorder, treatment with selective serotonin reuptake inhibitors, and cholesterol levels [6]

Journal of Clinical Psychopharmacology

Volumn 26, Issue 5, 2006, Pages 538-540

  Herrán, Andrés ^a   Ramírez, Maria L ^a   Carrera, Maria ^a   García Unzueta, Maria T ^a   Sierra Biddle, Deirdre ^a   Rodríguez Cabo, Beatriz ^a   Ayestarán, Ana ^a   Hoyuela, Fernando ^a   Vázquez Barquero, Jose L ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; CITALOPRAM; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ALCOHOL CONSUMPTION; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HEMOCONCENTRATION; HUMAN; HYPERCHOLESTEROLEMIA; LETTER; LIPID ANALYSIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PANIC; PRIORITY JOURNAL;

ADULT; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CITALOPRAM; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PANIC DISORDER; PAROXETINE; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TREATMENT OUTCOME;

EID: 33748752024     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000237941.56107.b7     Document Type: Letter

References (19)

1. Hayward C. Psychiatric illness and cardiovascular disease risk. Epidemiol Rev. 1995;17:129-138.
2. Kim EJ, Yu BH. Increased cholesterol levels after paroxetine treatment in patients with panic disorder. J Clin Psychopharmacol. 2005;25:597-599.
3. Herran A, Sierra-Biddle D, Garcia-Unzueta MT, et al. The acute phase response in panic disorder. Int J Neuropsychopharmacol. 2005;8:529-535.
4. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;(59 suppl):2022-2033.
5. Shear MK, Brown TA, Barlow DH, et al. Multicenter collaborative panic disorder severity scale. Am J Psychiatry. 1997;154:1571-1575.
6. Guy W. Early Clinical Evaluation Unit (ECDEU) Assessment Manual for Psychopharmacology. Revised. 17. Bethesda, MD: National Institute of Mental Health; 1976: 217-222.
7. Beck AT, Ward C, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961:561-571.
8. Spielberger CD, Gorusch RL, Lushene RE. Manual for the State-Trait Inventory (Self-evaluation Questionnaire). Palo Alto, CA: Consulting Psychologists Press; 1970.
9. Lasa L, Ayuso-Mateos JL, Vazquez-Barquero JL, et al. The use of the Beck Depression Inventory to screen for depression in the general population: a preliminary analysis. J Affect Disord. 2000;57:261-265.
10. Bajwa WK, Asnis GM, Sanderson WC, et al. High cholesterol levels in patients with panic disorder. Am J Psychiatry. 1992;149:376-378.
11. Feder R. High cholesterol levels in patients with panic disorder. Am J Psychiatry. 1993;150:527.
12. Hayward C, Taylor CB, Roth WT, et al. Plasma lipid levels in patients with panic disorder or agoraphobia. Am J Psychiatry. 1989;146:917-919.
13. Reifman A, Windle M. High cholesterol levels in patients with panic disorder. Am J Psychiatry. 1993;150:527.
14. Peter H, Hand I, Hohagen F, et al. Serum cholesterol level comparison: control subjects, anxiety disorder patients, and obsessive-compulsive disorder patients. Can J Psychiatry. 2002;47:557-561.
15. Lacerda AL, Caetano D, Caetano SC. Cholesterol levels in panic disorder, generalized anxiety disorder and major depression. Arq Neuropsiquiatr. 2000;58:408-411.
16. Shioiri T, Fujii K, Someya T, et al. Frequency distribution of serum cholesterol levels in patients with panic disorder: comparison with normal controls. Psychiatry Clin Neurosci. 1998;52:601-604.
17. Agargun MY, Algun E, Sekeroglu R, et al. Low cholesterol level in patients with panic disorder: the association with major depression. J Affect Disord. 1998;50:29-32.
18. Papakostas GI, Ongur D, Iosifescu DV, et al. Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses. Eur Neuropsychopharmacol. 2004;14:135-142.
19. Bailey DL, Le Melledo JM. Effects of selective serotonin reuptake inhibitors on cholesterol levels in patients with panic disorder. J Clin Psychopharmacol. 2003;23:317-319.